Supporting HIV care through education and innovation

Study: ADAP is Cost Effective

Study: ADAP is Cost Effective

Tuesday, October 23, 2012

Description

The HRSA Ryan White AIDS Drug Assistance Program (ADAP) is cost effective, according to a university study. The cost review, carried out by the Medical College of Wisconsin, also found that ADAP helps reduce the number of new infections by suppressing viral load of infected individuals, thus reducing the likelihood of transmission from infected to uninfected individuals.

According to the study, in 2008, ADAP:

  • Prevented 3,191 secondary infections.
  • Saved 24,922 quality-adjusted life years.
  • Saved $11,955 in net costs per quality-adjusted life year saved.

ADAP assists one-third of all patients living with HIV in the U.S.

See “Is the US AIDS Drug Assistance Program Cost-Effective?” by Pinkerton et al. in AIDS Behavior (2012 October 2).

See ADAP technical assistance and training resources.

 

Add a Comment

Log in or register to post comments